We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
Cap. Flow
-$12M
Cap. Flow %
-0.16%
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$68.6M
2
ARGX icon
argenx
ARGX
+$55M
3
SNY icon
Sanofi
SNY
+$50.7M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$50.5M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$42.3M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$48.6M
2
KDP icon
Keurig Dr Pepper
KDP
+$45.5M
3
INCY icon
Incyte
INCY
+$45.2M
4
UNH icon
UnitedHealth
UNH
+$37.3M
5
CPB icon
Campbell Soup
CPB
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 34.97%
2 Consumer Staples 5.35%
3 Consumer Discretionary 4.92%
4 Technology 3.86%
5 Communication Services 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATHX
376
DELISTED
Athersys, Inc. Common Stock
ATHX
– –
-383,000
Closed -$165K
CFRX
377
DELISTED
ContraFect Corporation
CFRX
– –
-475,000
Closed -$271K
12 13 14 15
16

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
  • Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
  • Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
  • Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
  • Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
  • Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
  • Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.